Brünner N - Search Results

1

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer.

Frederiksen C, Qvortrup C, Christensen IJ, Glimelius B, Berglund A, Jensen BV, Nielsen SE, Keldsen N, Nielsen HJ, Brünner N, Pfeiffer P. Frederiksen C, et al. Among authors: brunner n. Ann Oncol. 2011 Feb;22(2):369-75. doi: 10.1093/annonc/mdq354. Epub 2010 Jul 19. Ann Oncol. 2011. PMID: 20643864 Free article.

2

[Serological markers of colorectal cancer].

Nielsen HJ, Christensen IJ, Brünner NA. Nielsen HJ, et al. Ugeskr Laeger. 2005 Oct 31;167(44):4163-7. Ugeskr Laeger. 2005. PMID: 16266568 Review. Danish.

3

Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.

Holten-Andersen MN, Fenger C, Nielsen HJ, Rasmussen AS, Christensen IJ, Brünner N, Kronborg O. Holten-Andersen MN, et al. Among authors: brunner n. Eur J Cancer. 2004 Sep;40(14):2159-64. doi: 10.1016/j.ejca.2004.06.011. Eur J Cancer. 2004. PMID: 15341992

4

Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.

Lomholt AF, Frederiksen CB, Christensen IJ, Brünner N, Nielsen HJ. Lomholt AF, et al. Among authors: brunner n. Clin Chim Acta. 2007 May 1;380(1-2):128-32. doi: 10.1016/j.cca.2007.01.022. Epub 2007 Feb 1. Clin Chim Acta. 2007. PMID: 17328880

5

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid.

Sørensen NM, Byström P, Christensen IJ, Berglund A, Nielsen HJ, Brünner N, Glimelius B. Sørensen NM, et al. Among authors: brunner n. Clin Cancer Res. 2007 Jul 15;13(14):4117-22. doi: 10.1158/1078-0432.CCR-07-0186. Clin Cancer Res. 2007. PMID: 17634538 Clinical Trial.

6

A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.

Nielsen HJ, Christensen IJ, Brünner N. Nielsen HJ, et al. Among authors: brunner n. Scand J Gastroenterol. 2010;45(2):200-7. doi: 10.3109/00365520903429406. Scand J Gastroenterol. 2010. PMID: 20095885

7

Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer.

Aldulaymi B, Christensen IJ, Sölétormos G, Jess P, Nielsen SE, Brünner N, Nielsen HJ. Aldulaymi B, et al. Among authors: brunner n. Anticancer Res. 2010 Jan;30(1):233-7. Anticancer Res. 2010. PMID: 20150641

8

Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.

Nielsen HJ, Brünner N, Jorgensen LN, Olsen J, Rahr HB, Thygesen K, Hoyer U, Laurberg S, Stieber P, Blankenstein MA, Davis G, Dowell BL, Christensen IJ; Danish Endoscopy Study Group on Colorectal Cancer Detection; Danish Colorectal Cancer Cooperative Group. Nielsen HJ, et al. Among authors: brunner n. Scand J Gastroenterol. 2011 Jan;46(1):60-9. doi: 10.3109/00365521.2010.513060. Epub 2010 Aug 30. Scand J Gastroenterol. 2011. PMID: 20799911

9

Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.

Aldulaymi B, Christensen IJ, Sölétormos G, Jess P, Nielsen SE, Laurberg S, Brünner N, Nielsen HJ. Aldulaymi B, et al. Among authors: brunner n. Anticancer Res. 2010 Nov;30(11):4755-9. Anticancer Res. 2010. PMID: 21115936

10

High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcome.

Aldulaymi B, Byström P, Berglund A, Christensen IJ, Brünner N, Nielsen HJ, Glimelius B. Aldulaymi B, et al. Among authors: brunner n. Oncology. 2010;79(1-2):144-9. doi: 10.1159/000320686. Epub 2010 Dec 8. Oncology. 2010. PMID: 21150229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

593 results

Search Page